Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer

MLA

Falke, Johannes, et al. “Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer.” Journal of Urology, vol. 189, no. 6, June 2013, pp. 2077–82. EBSCOhost, https://doi.org/10.1016/j.juro.2012.11.150.

APA

Falke, J., Lammers, R. J. M., Arentsen, H. C., Ravic, M., Pozzi, R., Cornel, E. B., Vergunst, H., de Reijke, T. M., & Witjes, J. A. (2013). Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer. Journal of Urology, 189(6), 2077–2082. https://doi.org/10.1016/j.juro.2012.11.150

Chicago

Falke, Johannes, Rianne J.M. Lammers, Harm C. Arentsen, Miroslav Ravic, Raffaella Pozzi, Erik B. Cornel, Henk Vergunst, Theo M. de Reijke, and J. Alfred Witjes. 2013. “Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer.” Journal of Urology 189 (6): 2077–82. doi:10.1016/j.juro.2012.11.150.